Immune Mediated-colitis
3 clinical trials · Condition
◉ Watch Immune Mediated-colitis
| Record | Firm | Date |
|---|---|---|
| Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study (NCT04768504) | Khashayar Esfahani | 2022-03-22 |
| Vedolizumab for Immune Mediated Colitis (NCT04797325) | University of Copenhagen | 2021-08-30 |
Track Immune Mediated-colitis automatically
Every clearance here is in the API, with alerts when new ones post.